Cavalier Jason
Principal Financial Officer
Cavalier Jason has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Apr 3, 2026.
On the most recent filing, Cavalier Jason is listed as Chief Financial Officer at Lyra Therapeutics, Inc. Inside the rolling window, Cavalier Jason reported no open-market purchases and 1 open-market sale totaling $3K in LYRA.
Companies traded
Other insiders at LYRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cavalier Jason made?
Cavalier Jason has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Cavalier Jason trade?
Cavalier Jason has filed SEC Form 4 disclosures for 1 company, including LYRA.
When was Cavalier Jason's most recent SEC Form 4 filing?
Cavalier Jason's most recent SEC Form 4 filing on Tracefour is dated Apr 3, 2026.
What is Cavalier Jason's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Cavalier Jason is listed as Principal Financial Officer.
What is Cavalier Jason's total buy and sell value in the current window?
Inside the rolling retention window, Cavalier Jason bought $0 and sold $3K based on SEC Form 4 filings.
What was Cavalier Jason's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 769 LYRA shares on 2026-01-06, worth $3K, per SEC Form 4 filings.